MTB Fatty Acid Biosynthesis Enzyme Inhibitors (State University of New York at Stony Brook)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMTB Fatty Acid Biosynthesis Enzyme Inhibitors (State University of New York at Stony Brook)
Drug Alias NameInhA Inhibitors (State University of New York at Stony Brook)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibin alpha chain inhibitorsEnoyl-acyl-carrier protein reductase inhibitors
TargetsEnoyl-acyl-carrier protein reductaseInhibin alpha chain
Therapy Area/IndicationsMultidrug-Resistant InfectionTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesState University of New York at Stony Brook
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesState University of New York at Stony Brook
Active IndicationsN/A
Inactive IndicationsMultidrug-Resistant InfectionTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A